论文信息 - Heterogeneous information network and its application to human health and disease

Heterogeneous information network and its application to human health and disease

The molecular components with the functional interdependencies in human cell form complicated biological network. Diseases are mostly caused by the perturbations of the composite of the interaction multi-biomolecules, rather than an abnormality of a single biomolecule. Furthermore, new biological functions and processes could be revealed by discovering novel biological entity relationships. Hence, more and more biologists focus on studying the complex biological system instead of the individual biological components. The emergence of heterogeneous information network (HIN) offers a promising way to systematically explore complicated and heterogeneous relationships between various molecules for apparently distinct phenotypes. In this review, we first present the basic definition of HIN and the biological system considered as a complex HIN. Then, we discuss the topological properties of HIN and how these can be applied to detect network motif and functional module. Afterwards, methodologies of discovering relationships between disease and biomolecule are presented. Useful insights on how HIN aids in drug development and explores human interactome are provided. Finally, we analyze the challenges and opportunities for uncovering combinatorial patterns among pharmacogenomics and cell-type detection based on single-cell genomic data.

[1] Paul J Hergenrother,et al. Targeting RNA with small molecules. , 2008, Chemical reviews.

[2] Hui Liu,et al. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks , 2016, BMC Bioinformatics.

[3] Hui Xiao,et al. NONCODE v3.0: integrative annotation of long noncoding RNAs , 2011, Nucleic Acids Res..

[4] B. Barlogie,et al. Antitumor activity of thalidomide in refractory multiple myeloma. , 1999, The New England journal of medicine.

[5] T. Katsuya,et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. , 2012, Atherosclerosis.

[6] Eric E Schadt,et al. The role of macromolecular damage in aging and age-related disease. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7] Xing Chen,et al. Long non-coding RNAs and complex diseases: from experimental results to computational models , 2016, Briefings Bioinform..

[8] Cheng Liang,et al. Semi-supervised prediction of human miRNA-disease association based on graph regularization framework in heterogeneous networks , 2018, Neurocomputing.

[9] Xing Chen,et al. Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[10] Anton J. Enright,et al. An efficient algorithm for large-scale detection of protein families. , 2002, Nucleic acids research.

[11] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[12] Jiawei Luo,et al. A Novel Cluster-Based Computational Method to Identify miRNA Regulatory Modules , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[13] Trey Ideker,et al. Boosting Signal-to-Noise in Complex Biology: Prior Knowledge Is Power , 2011, Cell.

[14] A. Barabasi,et al. Network medicine--from obesity to the "diseasome". , 2007, The New England journal of medicine.

[15] Xing Chen,et al. Inferring potential small molecule–miRNA association based on triple layer heterogeneous network , 2018, Journal of Cheminformatics.

[16] M. Oti,et al. The modular nature of genetic diseases , 2006, Clinical genetics.

[17] David S. Wishart,et al. HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..

[18] Xing Chen,et al. In Silico Prediction of Small Molecule-miRNA Associations Based on the HeteSim Algorithm , 2018, Molecular therapy. Nucleic acids.

[19] Xiangrong Liu,et al. deepDR: a network-based deep learning approach to in silico drug repositioning , 2019, Bioinform..

[20] Sebastian Wernicke,et al. FANMOD: a tool for fast network motif detection , 2006, Bioinform..

[21] Hyeong Jun An,et al. Estimating the size of the human interactome , 2008, Proceedings of the National Academy of Sciences.

[22] Jörg Rademann,et al. Lysosomal Pathology and Osteopetrosis upon Loss of H+-Driven Lysosomal Cl– Accumulation , 2010, Science.

[23] Yang Li,et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[24] Chee Keong Kwoh,et al. Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[25] Juan Liu,et al. A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules , 2011, Bioinform..

[26] Wei Lin,et al. A comprehensive overview and evaluation of circular RNA detection tools , 2017, PLoS Comput. Biol..

[27] Ao Li,et al. Relevance search for predicting lncRNA-protein interactions based on heterogeneous network , 2016, Neurocomputing.

[28] Xin Yao,et al. Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network , 2011, BMC Systems Biology.

[29] Qianlan Yao,et al. Prioritizing Candidate Disease Metabolites Based on Global Functional Relationships between Metabolites in the Context of Metabolic Pathways , 2014, PloS one.

[30] Decheng Yang,et al. MicroRNA: an Emerging Therapeutic Target and Intervention Tool , 2008, International journal of molecular sciences.

[31] Ka-Chun Wong,et al. ToBio: Global Pathway Similarity Search Based on Topological and Biological Features , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[32] Yongdong Zhang,et al. Drug-target interaction prediction: databases, web servers and computational models , 2016, Briefings Bioinform..

[33] Xiangxiang Zeng,et al. Inferring MicroRNA-Disease Associations by Random Walk on a Heterogeneous Network with Multiple Data Sources , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[34] Sune Lehmann,et al. Link communities reveal multiscale complexity in networks , 2009, Nature.

[35] Ao Li,et al. A Heterogeneous Network Based Method for Identifying GBM-Related Genes by Integrating Multi-Dimensional Data , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[36] J. Lehár,et al. Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.

[37] Cheng Liang,et al. A graph regularized non-negative matrix factorization method for identifying microRNA-disease associations , 2018, Bioinform..

[38] M E J Newman,et al. Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39] Zuping Zhang,et al. miRDDCR: a miRNA-based method to comprehensively infer drug-disease causal relationships , 2017, Scientific Reports.

[40] Tingting Fu,et al. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics , 2017, Nucleic Acids Res..

[41] Jing Li,et al. dbDEPC 2.0: updated database of differentially expressed proteins in human cancers , 2011, Nucleic Acids Res..

[42] Yi Pan,et al. miRTRS: A Recommendation Algorithm for Predicting miRNA Targets , 2020, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[43] Lei Wang,et al. BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction , 2018, Bioinform..

[44] Yitzhak Pilpel,et al. Global and Local Architecture of the Mammalian microRNA–Transcription Factor Regulatory Network , 2007, PLoS Comput. Biol..

[45] Xing Chen,et al. PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction , 2017, PLoS Comput. Biol..

[46] Yingming Zhao,et al. Modification‐specific proteomics: Strategies for characterization of post‐translational modifications using enrichment techniques , 2009, Proteomics.

[47] Junwei Han,et al. Global Prioritization of Disease Candidate Metabolites Based on a Multi-omics Composite Network , 2015, Scientific Reports.

[48] Xing Chen,et al. LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association prediction , 2017, PLoS Comput. Biol..

[49] B. Al-Lazikani,et al. Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.

[50] C. Ponting,et al. Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[51] Cheng Liang,et al. A novel motif-discovery algorithm to identify co-regulatory motifs in large transcription factor and microRNA co-regulatory networks in human , 2015, Bioinform..

[52] An-Yuan Guo,et al. Transcription factor and microRNA co-regulatory loops: important regulatory motifs in biological processes and diseases , 2015, Briefings Bioinform..

[53] Wei Huang,et al. A Novel Approach to Identify the miRNA-mRNA Causal Regulatory Modules in Cancer , 2018, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[54] Kinya Otsu,et al. Macromolecular Degradation Systems and Cardiovascular Aging. , 2016, Circulation research.

[55] Artemis G. Hatzigeorgiou,et al. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions , 2017, Nucleic Acids Res..

[56] Albertha J. M. Walhout,et al. The interplay between transcription factors and microRNAs in genome‐scale regulatory networks , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[57] Jiawei Luo,et al. A novel approach for predicting microRNA-disease associations by unbalanced bi-random walk on heterogeneous network , 2017, J. Biomed. Informatics.

[58] Michelle R. Arkin,et al. Small-molecule inhibitors of protein–protein interactions: progressing towards the dream , 2004, Nature Reviews Drug Discovery.

[59] Hyeon-Eui Kim,et al. Deep mining heterogeneous networks of biomedical linked data to predict novel drug‐target associations , 2017, Bioinform..

[60] R. Kuang,et al. Network-based Phenome-Genome Association Prediction by Bi-Random Walk , 2015, PloS one.

[61] T. Chou. Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.

[62] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.

[63] T. Vicsek,et al. Uncovering the overlapping community structure of complex networks in nature and society , 2005, Nature.

[64] U. Alon. Network motifs: theory and experimental approaches , 2007, Nature Reviews Genetics.

[65] Xing Chen,et al. EGBMMDA: Extreme Gradient Boosting Machine for MiRNA-Disease Association prediction , 2018, Cell Death & Disease.

[66] Qinghua Guo,et al. LncRNA2Target v2.0: a comprehensive database for target genes of lncRNAs in human and mouse , 2018, Nucleic Acids Res..

[67] Dapeng Hao,et al. Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. , 2015, Molecular bioSystems.

[68] Ana Kozomara,et al. miRBase: from microRNA sequences to function , 2018, Nucleic Acids Res..

[69] Jinyan Li,et al. Disease gene identification by random walk on multigraphs merging heterogeneous genomic and phenotype data , 2012, BMC Genomics.

[70] Vipin Kumar,et al. Co-clustering phenome–genome for phenotype classification and disease gene discovery , 2012, Nucleic acids research.

[71] Xin Chen,et al. DCDB 2.0: a major update of the drug combination database , 2014, Database J. Biol. Databases Curation.

[72] Cheng Liang,et al. A novel semi-supervised model for miRNA-disease association prediction based on \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{d , 2018, Journal of Translational Medicine.

[73] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[74] J. Mattick. The Genetic Signatures of Noncoding RNAs , 2009, PLoS genetics.

[75] Xiangxiang Zeng,et al. Integrative approaches for predicting microRNA function and prioritizing disease-related microRNA using biological interaction networks , 2016, Briefings Bioinform..

[76] Zhi-yi Zhang,et al. Biotransformation and in vitro assessment of metabolism-associated drug-drug interaction for CRx-102, a novel combination drug candidate. , 2009, Journal of pharmaceutical and biomedical analysis.

[77] Xing Chen,et al. MDHGI: Matrix Decomposition and Heterogeneous Graph Inference for miRNA-disease association prediction , 2018, PLoS Comput. Biol..

[78] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.

[79] Xiangxiang Zeng,et al. Probability-based collaborative filtering model for predicting gene–disease associations , 2017, BMC Medical Genomics.

[80] Xing Chen,et al. NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning , 2016, PLoS Comput. Biol..

[81] Haiyuan Yu,et al. Detecting overlapping protein complexes in protein-protein interaction networks , 2012, Nature Methods.

[82] Jingpu Zhang,et al. Integrating Multiple Heterogeneous Networks for Novel LncRNA-Disease Association Inference , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[83] Ivan G. Costa,et al. A multiple kernel learning algorithm for drug-target interaction prediction , 2016, BMC Bioinformatics.

[84] Svetlana A. Shabalina,et al. Negative Correlation between Expression Level and Evolutionary Rate of Long Intergenic Noncoding RNAs , 2011, Genome biology and evolution.

[85] Ariel Chernomoretz,et al. A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases , 2016, PLoS neglected tropical diseases.

[86] Yi Pan,et al. SinNLRR: a robust subspace clustering method for cell type detection by non-negative and low-rank representation , 2019, Bioinform..

[87] Jiawei Luo,et al. A path-based measurement for human miRNA functional similarities using miRNA-disease associations , 2016, Scientific Reports.

[88] Kate Traynor. FDA approves four-drug anti-HIV combination tablet. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[89] Jing Wang,et al. Identifying novel associations between small molecules and miRNAs based on integrated molecular networks , 2015, Bioinform..

[90] A. Barabasi,et al. Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[91] Zhiwei Cao,et al. Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer , 2015, Nature Communications.

[92] Rory Johnson. Long non-coding RNAs in Huntington's disease neurodegeneration , 2012, Neurobiology of Disease.

[93] Xing Chen,et al. ASDCD: Antifungal Synergistic Drug Combination Database , 2014, PloS one.

[94] David S. Wishart,et al. Chapter 3: Small Molecules and Disease , 2012, PLoS Comput. Biol..

[95] Duncan Fyfe Gillies,et al. A Review of Feature Selection and Feature Extraction Methods Applied on Microarray Data , 2015, Adv. Bioinformatics.

[96] Jian-Yu Shi,et al. Predicting binary, discrete and continued lncRNA-disease associations via a unified framework based on graph regression , 2017, BMC Medical Genomics.

[97] D Hare,et al. The Orange Book: the Food and Drug Administration's advice on therapeutic equivalence. , 1990, American pharmacy.

[98] Ao Li,et al. Discovery of Bladder Cancer-related Genes Using Integrative Heterogeneous Network Modeling of Multi-omics Data , 2017, Scientific Reports.

[99] Shi-Hua Zhang,et al. Integrative analysis for identifying joint modular patterns of gene-expression and drug-response data , 2016, Bioinform..

[100] P. Pandolfi,et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. , 1998, The New England journal of medicine.